IL186548A0 - Treatment of severe community-acquired pneumonia by administration of tissue factory pathway inhibitor(tfpi) - Google Patents
Treatment of severe community-acquired pneumonia by administration of tissue factory pathway inhibitor(tfpi)Info
- Publication number
- IL186548A0 IL186548A0 IL186548A IL18654807A IL186548A0 IL 186548 A0 IL186548 A0 IL 186548A0 IL 186548 A IL186548 A IL 186548A IL 18654807 A IL18654807 A IL 18654807A IL 186548 A0 IL186548 A0 IL 186548A0
- Authority
- IL
- Israel
- Prior art keywords
- tfpi
- administration
- treatment
- pathway inhibitor
- acquired pneumonia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67146605P | 2005-04-15 | 2005-04-15 | |
| PCT/US2006/013890 WO2006113360A2 (en) | 2005-04-15 | 2006-04-14 | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL186548A0 true IL186548A0 (en) | 2008-01-20 |
Family
ID=36951247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL186548A IL186548A0 (en) | 2005-04-15 | 2007-10-10 | Treatment of severe community-acquired pneumonia by administration of tissue factory pathway inhibitor(tfpi) |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1871408A2 (en) |
| JP (1) | JP2008536859A (en) |
| KR (1) | KR20080033151A (en) |
| CN (1) | CN101180074A (en) |
| AU (1) | AU2006236698A1 (en) |
| BR (1) | BRPI0610549A2 (en) |
| CA (1) | CA2605057A1 (en) |
| IL (1) | IL186548A0 (en) |
| MX (1) | MX2007012619A (en) |
| RU (1) | RU2007142192A (en) |
| TN (1) | TNSN07386A1 (en) |
| WO (1) | WO2006113360A2 (en) |
| ZA (1) | ZA200708700B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009129164A1 (en) * | 2008-04-15 | 2009-10-22 | Novartis Ag | Pharmaceutical combinations of tfpi-fragments and an antibiotic |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1604790A (en) * | 2001-10-15 | 2005-04-06 | 希龙公司 | Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
-
2006
- 2006-04-14 KR KR1020077026568A patent/KR20080033151A/en not_active Application Discontinuation
- 2006-04-14 WO PCT/US2006/013890 patent/WO2006113360A2/en active Application Filing
- 2006-04-14 EP EP06750055A patent/EP1871408A2/en not_active Withdrawn
- 2006-04-14 CN CNA2006800173396A patent/CN101180074A/en active Pending
- 2006-04-14 CA CA002605057A patent/CA2605057A1/en not_active Abandoned
- 2006-04-14 JP JP2008506694A patent/JP2008536859A/en not_active Withdrawn
- 2006-04-14 AU AU2006236698A patent/AU2006236698A1/en not_active Abandoned
- 2006-04-14 MX MX2007012619A patent/MX2007012619A/en not_active Application Discontinuation
- 2006-04-14 RU RU2007142192/14A patent/RU2007142192A/en not_active Application Discontinuation
- 2006-04-14 BR BRPI0610549-1A patent/BRPI0610549A2/en not_active IP Right Cessation
-
2007
- 2007-10-10 IL IL186548A patent/IL186548A0/en unknown
- 2007-10-11 TN TNP2007000386A patent/TNSN07386A1/en unknown
-
2008
- 2008-10-11 ZA ZA200708700A patent/ZA200708700B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006113360A3 (en) | 2007-04-12 |
| JP2008536859A (en) | 2008-09-11 |
| BRPI0610549A2 (en) | 2010-07-06 |
| EP1871408A2 (en) | 2008-01-02 |
| MX2007012619A (en) | 2008-01-11 |
| CA2605057A1 (en) | 2006-10-26 |
| KR20080033151A (en) | 2008-04-16 |
| WO2006113360A2 (en) | 2006-10-26 |
| AU2006236698A1 (en) | 2006-10-26 |
| TNSN07386A1 (en) | 2009-03-17 |
| ZA200708700B (en) | 2008-12-31 |
| CN101180074A (en) | 2008-05-14 |
| RU2007142192A (en) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1500034I1 (en) | Indolidone derivatives for the treatment or prevention of fibrotic diseases | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| ZA200709520B (en) | Use of TFPI to treat severe bacterial infections | |
| WO2007148185A3 (en) | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors | |
| RS52874B (en) | Thiophene analogues for the treatment or prevention of flavivirus infections | |
| WO2010042163A3 (en) | Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders | |
| NO20090313L (en) | Derivatives and analogs of N-ethylquinolones and N-ethyllazakinolones | |
| WO2008022286A3 (en) | Small molecule inhibitors of kynurenine-3-monooxygenase | |
| ZA200902270B (en) | Hydrobenzamide derivatives as inhibitors of hsp90 | |
| IL193252A0 (en) | N-hydroxyacrylamide compounds | |
| IL178207A0 (en) | Dalbavancin compositions for treatment of bacterial infections | |
| ZA200704392B (en) | Antibiotic combinations for providing total solution to the treatment of infections | |
| NO20085051L (en) | Treatment of gastrointestinal disorders with CGRP antagonists | |
| HUP0501111A2 (en) | Treatment of severe pneumonia by administration of tissue factor pathway inhibitor | |
| GB0513096D0 (en) | Treatment of microbial infections | |
| ZA200704775B (en) | Compositions for treatment of ear infections | |
| IL182055A0 (en) | Agent for prophylaxis or treatment of metabolic syndrome | |
| IL186548A0 (en) | Treatment of severe community-acquired pneumonia by administration of tissue factory pathway inhibitor(tfpi) | |
| IL178115A0 (en) | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) | |
| WO2008021439A3 (en) | Compositions and methods for treatment of cardiac hypertrophy | |
| WO2007089735A3 (en) | Potassium channel inhibitors | |
| EP1951194A4 (en) | Antimicrobial decapeptide oral hygiene treatment | |
| NO20083352L (en) | 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof | |
| MA30730B1 (en) | TREATMENT OF SEVERE EXTRA-HOSPITAL PNEUMONIA BY ADMINISTRATION OF THE TISSUE FACTOR PATH INHIBITOR (TFPI) |